Faculty of Medicine and Health Technology, Clinical Medicine, Tampere University, FI-33014, Tampere University, Finland; Development and Information Services, Finnish Medicines Agency Fimea, P.O. Box 55, FI-00034, FIMEA, Finland.
Development and Information Services, Finnish Medicines Agency Fimea, P.O. Box 55, FI-00034, FIMEA, Finland.
Res Social Adm Pharm. 2023 Oct;19(10):1372-1379. doi: 10.1016/j.sapharm.2023.06.005. Epub 2023 Jun 17.
Certain medications should be used with caution in older persons, which challenges rational prescribing. Potentially inappropriate medications (PIMs) are defined as medicines whose potential risk of harm typically outweighs the clinical benefits in geriatric population. Earlier studies have found regional differences in PIM use, but the factors underlying this phenomenon are unclear.
To compare prescription PIM prevalence among Finnish hospital districts and determine which population characteristics and factors related to social and health care are associated with regional variation.
This nationwide register study was based on the Prescription Centre data on all people aged ≥75 years in 2017-2019. Hospital district (n = 20) characteristics were drawn from the Finnish Institute for Health and Welfare's, Finnish Medical Association's, and Finnish Medicines Agency's publicly open data. PIMs were defined according to the Finnish Meds75+ database. A linear mixed-effect model was used to analyze potential associations of regional characteristics with PIM prevalence.
Prevalence of PIMs varied between 16.4% and 24.8% across regions. The highest prevalence was observed in the southern regions, while the lowest prevalence was on the west coast. Hospital district characteristics associated with higher PIM prevalence were higher share of population living alone, with excessive polypharmacy, or assessed using the Resident Assessment Instrument, shortage of general practitioners in municipal health centers, and low share of home care personnel. Waiting time in health care or share of population with morbidities were not associated with PIM use. Of the total variance in PIM prevalence, 86% was explained by group-level factors related to hospital districts. The regional variables explained 75% of this hospital-district-level variation.
PIM prevalence varied significantly across hospital districts. Findings suggest that higher PIM prevalence may be related to challenges in the continuity of care rather than differences in health care accessibility or share of the population with morbidities.
某些药物在老年人中应谨慎使用,这给合理用药带来了挑战。潜在不适当药物(PIMs)被定义为在老年人群体中,其潜在风险通常大于临床获益的药物。早期研究发现 PIM 使用存在地域差异,但这种现象的背后因素尚不清楚。
比较芬兰各医院区处方 PIM 的流行率,并确定与地域差异相关的人口特征和与社会及卫生保健相关的因素。
本全国性的基于注册研究基于 2017-2019 年所有≥75 岁人群的处方中心数据。从芬兰卫生福利研究所、芬兰医师协会和芬兰药品管理局的公开数据中提取医院区特征。根据芬兰 Meds75+数据库定义 PIMs。采用线性混合效应模型分析地域特征与 PIM 流行率之间的潜在关联。
各区域的 PIM 流行率在 16.4%至 24.8%之间存在差异。南部地区的流行率最高,而西海岸的流行率最低。与较高 PIM 流行率相关的医院区特征包括:独居人口比例较高、过度多种药物治疗或使用 Resident Assessment Instrument 评估、市卫生中心的全科医生短缺、家庭护理人员比例较低。医疗保健的等待时间或患有多种疾病的人口比例与 PIM 使用无关。在 PIM 流行率的总方差中,86%可由与医院区相关的组间因素解释。地域变量解释了这一医院区层面差异的 75%。
PIM 流行率在各医院区之间存在显著差异。研究结果表明,较高的 PIM 流行率可能与医疗连续性方面的挑战有关,而与医疗保健可及性或患有多种疾病的人口比例无关。